May 12, 2025
Explore key insights from our Investment Strategy & Research (IS&R) team’s second-quarter 2025 market outlook. This brief touches on shifting global trade dynamics, policy uncertainty, consumer and labor trends and how they shape long-term investment strategy. For a deeper dive, access the full Insight.
Markets in 2025 are contending with a meaningful shift in the global economic order—one defined by rising economic nationalism and a retreat from decades of globalization. In the U.S., policymakers are increasingly prioritizing industrial resilience and domestic production over cross-border efficiency, fueling a broader reorientation of trade policy.
One of the clearest expressions of this shift is the Trump administration’s recently proposed tariff package. Initially projected to raise the average effective tariff rate from 2.5% to as high as 25% across U.S. trading partners, subsequent negotiations with more than 50 countries—including China—have tempered estimates to a 10% to 20% range.
While elevated by modern standards, Figure 1 shows that tariffs at or above these levels were historically common during earlier periods of U.S. protectionism.
We remain in the early stages of this transition. The long-term effects will depend on how costs are shared across supply chains. Producers may absorb some pressure, but for essential or specialized goods, consumers could face higher prices. In either case, trade barriers typically reduce transaction volume, slow economic growth and add friction to an already complex system.
Adding to today’s sense of unease is the shadow cast by an unprecedented stretch of market performance. From 2010 through 2024, U.S. large-cap equities delivered the highest rolling 15-year excess return over short-term government yields—typically measured by 3-month Treasury bills—since 1950, more than double the historical average, as illustrated in Figure 2. For many investors, this era redefined what market success can look like.
This outperformance was underwritten by an unusually accommodative policy environment. Interest rates remained below 1% for much of the period, while the Fed expanded its balance sheet by over $5 trillion through quantitative easing. Fiscal policy was similarly expansive, with deficits averaging more than twice the historical norm. At the same time, equity markets were reshaped by the rise of dominant technology platforms, as a handful of mega-cap firms— publicly traded companies with market capitalizations typically over $200 billion—now make up nearly 30% of the S&P 500 and account for more than $17 trillion in market value added since 2009.
Though supported by strong fundamentals, these gains were amplified by stretched valuations and a historically low cost of capital—conditions unlikely to persist. As a result, today’s unease reflects not only geopolitical or policy risks, but the broader challenge of recalibrating expectations after an extraordinary period of market growth.
Download Insight brief | Download full Insight analysis |
Aspiriant is an investment adviser registered with the Securities and Exchange Commission (SEC), which does not suggest a certain level of skill and training. Additional information regarding Aspiriant and its advisory practices can be obtained via the following link: aspiriant.com.
Information contained herein is considered confidential, private and Aspiriant proprietary inside information that is intended only for the audience to which Aspiriant has knowingly distributed this presentation to, either by way of request or voluntarily. Any redistribution of this material without our prior express written permission is a violation of Aspirant’s privacy policy adopted to comport with various state and federal privacy laws that may subject any unauthorized distributor to legal action.
All opinions, figures, charts/graphs, estimates and data included in this document are as on date and are subject to change without notice. The statements contained herein may include statements of future expectations, for general market performance or economic conditions, and other forward-looking statements that are based on our current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements. Forecasts, projections and other forward-looking statements are based upon assumptions, current beliefs and expectations. Forward-looking statements are subject to numerous assumptions, estimates, risks and uncertainties, including but not limited to: economic, business, market and geopolitical conditions; U.S. and foreign regulatory developments relating to, among other things, financial institutions and markets, government oversight, fiscal and tax policy. Any forward-looking information should not be regarded as a representation by Aspiriant or any other person that estimates or expectations contemplated will be achieved, as the future is not predictable.
Past performance is not indicative of future results. There can be no assurances that any strategy will meet its investment objectives. All investments can lose value. The performance and volatility of an investor’s portfolio will not be the same as the index. Indices are unmanaged and have no fees. An investment may not be made directly in an index. The data used in this material was obtained from third-party sources the firm believes are reliable and internally. Aspiriant is not responsible for the accuracy of any third-party data used in the construction of this presentation. This information alone is not sufficient and should not be used for the development or implementation of an investment strategy. It should not be construed as investment advice to any party. Investing in securities, such as equity, fixed income and mutual funds, involves the risk of partial or complete loss of capital that prospective investors should be prepared to bear. Any reference to securities, directly or indirectly, is not a recommendation and does not represent a solicitation to buy or an offer of a solicitation to sell such securities. Any statistical information contained herein has been obtained from publicly available market data (such as, but not limited to, data published by Bloomberg Finance L.P. and its affiliates), internal research and regulatory filings.
Want the latest wealth management tips, investment insights and Aspiriant news delivered straight to your inbox. Sign up for regular Fathom updates so we can send you the most relevant content you selected below.